secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIPELLA PHARMACEUTICALS INC. (LIPO)
CIK:        0001347242
Form:       8-K
Filed at:   2024-12-20T23:59:59+00:00
Accession:  0001753926-24-002130
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Lipella Pharma special meeting adjourned due to lack of quorum; reconvenes Dec 27
--------------------------------------------------------------------------------

- Special meeting on Dec 20, 2024 lacked a quorum; adjourned to Dec 27, 2024 at 2:00 p.m. ET.
- Valid proxies submitted before original meeting remain valid for reconvened meeting unless revoked.
- No proposals were voted on; meeting was virtual.
- Company filed definitive proxy statement on Nov 12, 2024 for the special meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347242/000175392624002130/0001753926-24-002130-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347242/000175392624002130/g084611_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-24-002130

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer